NCT05181956

Brief Summary

Study is to

  1. 1.Understand the pattern of hepatitis delta screening among medical providers for Asian patients with chronic hepatitis B
  2. 2.Determine the proportion of Asian hepatitis B patients who have been screened and who have chronic hepatitis delta
  3. 3.Determine the pattern of hepatitis delta screening after education of medical providers on hepatitis delta

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
5,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2022

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 20, 2021

Completed
14 days until next milestone

Study Start

First participant enrolled

January 3, 2022

Completed
7 days until next milestone

First Posted

Study publicly available on registry

January 10, 2022

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2022

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2023

Completed
Last Updated

January 10, 2022

Status Verified

December 1, 2021

Enrollment Period

12 months

First QC Date

December 20, 2021

Last Update Submit

December 20, 2021

Conditions

Chronic Hepatitis D Infection With Hepatitis B

Outcome Measures

Primary Outcomes (2)

  • Prevalence rate of chronic HDV

    Measure prevalence rate of chronic HDV among disaggregated Asian CHB patients through retrospective and prospective testing

    12 months

  • Characteristics of Asian patients with chronic HDV

    Describe demographic and clinical characteristics of Asian patients with chronic HDV

    12 months

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

18 years and older chronic hepatitis B patients

You may qualify if:

  • years and older chronic hepatitis B patients

You may not qualify if:

  • years and younger chronic hepatitis B patients

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Asian Pacific Liver Center

Los Angeles, California, 90020, United States

Location

Central Study Contacts

Mimi Chang, D.N.P.

CONTACT

2133871009mimi.chang@cimtoday.org

Tse-Ling Fong, M.D.

CONTACT

2133871009tselingf@usc.edu

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
OTHER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 20, 2021

First Posted

January 10, 2022

Study Start

January 3, 2022

Primary Completion

December 31, 2022

Study Completion

March 31, 2023

Last Updated

January 10, 2022

Record last verified: 2021-12

Locations

US(1)